 |
|
|
|
Dr. Daniel Joshua Drucker is on the Scientific Advisory Board of Glenmark Pharmaceuticals Limited. He is presently Director, Banting and Best Diabetes Centre University of Toronto, Toronto General Hospital. |
|
In his career, Dr. Drucker has also been associated with institutions like the John Hopkins Hospital and the Massachusetts General Hospital. Additionally, he has also been appointed to several committees, and he continues to have a long-standing association with some of them even today, viz. Banting and Best Diabetes Center Executive Committee [since 1991], University of Toronto Endocrinology Executive [since 1989] and, UHN-Mt. Sinai Economics Committee [since 2001]. Dr. Drucker has about 22 patents and close to 200 peer-reviewed publications to his credit. He has received peer-reviewed grant support for his work in glucagons gene expression and the GLP-1 receptor since 1987. He is the recipient of many international awards and honours, for his work in the field of Internal Medicine by numerous scientific organisations across Canada and the US; the latest being the University Health Network Inventor of the Year Award in 2005. He has been a prominent member of American Diabetes Association [ADA] contributing his best for the treatment of Diabetes.
Dr. Drucker received his M. D. from the University of Toronto in 1980. He also holds a Centennial Fellowship from the Medical Research Council of Canada and a Research Fellowship in Medicine from the Massachusetts General Hospital, Harvard University, Boston.
|
| |
|
 |
|
|
| Dr. Arpad Szallasi, a member of Glenmark's Scientific Advisory Board, and is currently affiliated to the Monmouth Medical Centre as Pathologist and Medical Director for the Transfusion Services. He is also concurrently associated with the Drexel University College of Medicine, Philadelphia as Adjunct Professor of Pathology, Department of Pathology and Laboratory Medicine. |
|
Prior to this, Dr. Szallsi was a Special Expert at the National Cancer Institute, Maryland [USA] and started his career as Chief Lab. Biochemistry, Dept. Pharmacology, Menarini Ricerche Sud, Italy. In addition, he has also been advisor to Nomenclature Supplement, Elsevier Trends Journals since 1998, besides chairing a number of committees. |
|
He has to his credit 3 patents and close to 60 published full length papers, all of which have been peer–reviewed. This is in addition to several reviews, book chapters and presentations, many of which he has co–authored. His research has been featured twice in Chemical & Engineering News and once in JAMA and he has been the receptor of several honours and awards. He has also advised, mentored and tutored several PhD students across Hungary, Sweden and Italy. Dr. Szallasi holds a PhD in Pharmacology from the Karolinska Institute in Stockholm. He graduated ‘summa cum laude’ from the University Medical School, Debrecen, Hungary in 1984. He has to his credit 20 years of post–graduate training, his last posting being as Fellow in Hematopathology, Hospital of the University of Pennsylvania and Children’s Hospital of Philadelphia in 2004.
|
|